Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage REAX Q1 2026 Earnings Narrowing Losses with Strong Earnings Beat CRSP Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline CVEO Q1 2026 Earnings Solid EPS Beat Provides Modest Glimmer Amid Seasonal Headwinds SPCE Q1 2026 Earnings Narrower Than Expected Loss as Company Reshapes Space Tourism Strategy SUPV Q1 2026 Earnings Massive EPS Beat Surprises Market Stock Declines Despite Strong Performance